The high professional level of our center was confirmed during the sponsor's visit to evaluate the quality of a phase III clinical trial to assess the safety and immunogenicity of the drug GNR-086 conducted at our research center. Thank you for your comments and suggestions, which we will definitely take into account in our future work.

Employees of the OLLA-MED LLC center took an active part in the scientific conference, listened to reports from leading scientists, experts from regulatory authorities of the EAEU countries, representatives of research centers, contract research organizations and educational institutions, Russian and foreign pharmaceutical companies. Thanks to the organizers for the opportunity to meet with colleagues face-to-face!

OLLA-MED LLC celebrates the anniversary date – five years since the foundation of the Clinical Trials Department. There are more than 40 successfully conducted protocols, hundreds of treated patients and successfully completed audits. We hope that a successful start will be the key to new victories and achievements. Happy anniversary!

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen